Although we demonstrate the possibility of application of anti-IFNγ antibody to restore vascular integrity for drug delivery in this study, the neutralising anti-IFNγ antibody might have dosage-dependent effects on the treatment of tumour that needs further studies in different treatment conditions. This evidence concerns the gene IFNG and neoplasm.